Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/67085
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFarouque, H.-
dc.contributor.authorSanders, P.-
dc.contributor.authorYoung, G.-
dc.date.issued2000-
dc.identifier.citationAmerican Journal of Cardiology, 2000; 86(11):1270-1272-
dc.identifier.issn0002-9149-
dc.identifier.issn1879-1913-
dc.identifier.urihttp://hdl.handle.net/2440/67085-
dc.description.abstractThe efficacy of intravenous magnesium in terminating sustained monomorphic ventricular tachycardia was examined in this study. This therapy was found to be ineffective in aborting monomorphic ventricular tachycardia induced in the electrophysiology laboratory.-
dc.description.statementofresponsibilityH.M. Omar Farouque, Prashanthan Sanders and Glenn D. Young-
dc.language.isoen-
dc.publisherExcerpta Medica Inc.-
dc.rightsCopyright © 2000 Excerpta Medica Inc. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/s0002-9149(00)01219-4-
dc.subjectHumans-
dc.subjectTachycardia, Ventricular-
dc.subjectCoronary Disease-
dc.subjectMagnesium Sulfate-
dc.subjectAnti-Arrhythmia Agents-
dc.subjectElectrocardiography-
dc.subjectTreatment Outcome-
dc.subjectInfusions, Intravenous-
dc.subjectHeart Rate-
dc.subjectMiddle Aged-
dc.subjectFemale-
dc.subjectMale-
dc.titleIntravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease-
dc.typeJournal article-
dc.identifier.doi10.1016/S0002-9149(00)01219-4-
pubs.publication-statusPublished-
dc.identifier.orcidSanders, P. [0000-0003-3803-8429]-
Appears in Collections:Aurora harvest 5
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.